Exelixis, Inc.
EXELNASDAQHealthcare● Active
$52.51
+$0.77(+1.49%)
Market Cap$13.2B
P/E Ratio—
52W High$53.24
52W Low$33.76
Exelixis, Inc.（EXEL）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EXEL · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2026-01 | 2025-01 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $0.78B | $0.52B | $0.21B | $0.18B | $0.23B |
| Depreciation & Amort. | $0.03B | $0.03B | $0.03B | $0.02B | $0.01B |
| Stock-Based Comp. | $0.11B | $0.09B | $0.11B | $0.11B | $0.12B |
| Change in Working Capital | ($0.19B) | ($0.01B) | ($0.01B) | ($0.01B) | ($0.04B) |
| Net Cash from Operations | $0.88B | $0.70B | $0.33B | $0.36B | $0.40B |
| Investing Activities | |||||
| Capital Expenditure | ($0.04B) | ($0.07B) | ($0.16B) | ($0.14B) | ($0.06B) |
| Purchases of Investments | ($0.61B) | ($0.93B) | ($0.90B) | ($1.45B) | ($1.36B) |
| Sales of Investments | $1.02B | $0.88B | $1.04B | $1.06B | $1.38B |
| Net Cash from Investing | $0.35B | ($0.12B) | ($0.03B) | ($0.52B) | ($0.04B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.95B) | ($0.65B) | ($0.55B) | $0.00B | $0.00B |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Financing | ($0.97B) | ($0.63B) | ($0.55B) | $0.00B | ($0.01B) |
| Free Cash Flow | |||||
| Free Cash Flow | $0.84B | $0.63B | $0.17B | $0.22B | $0.34B |
| FCF Margin %(computed) | 36.39% | 29.22% | 9.31% | 13.91% | 23.46% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Exelixis, Inc.
关于Exelixis, Inc.（EXEL）现金流量表
Exelixis, Inc. 2026财年经营活动现金流$0.88B，自由现金流$0.84B（FCF利润率36.39%），资本支出($0.04B)。
常见问题
EXEL · 4 问Exelixis, Inc. 2026财年自由现金流$0.84B，同比up33.2%。
EXEL free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10